Systemic Delivery of Aptamer-Conjugated XBP1 siRNA Nanoparticles for Efficient Suppression of HER2+ Breast Cancer.

Abstract

siRNA therapeutics as an emerging class of drug development is successfully coming to clinical utilization. The RNA-based therapy is widely utilized to explore the mechanism and cure a variety of gene-specific diseases. Tumor is an oncogene-driven disease; many genes are related to tumor progression and chemoresistance. Although human epidermal growth factor receptor 2 (HER2)-targeted monoclonal antibody therapy has dramatically improved the survival rate, chemotherapy remains essential to HER2-positive (HER2+) breast cancer patients. Recently, X-box binding protein 1 (XBP1) has been involved in triple-negative breast cancer (TNBC) chemoresistance and progression, but its function in HER2+ breast cancer is poorly explored. Here, we silenced XBP1 expression using RNase-resistant RNA nanoparticles (NPs). Intravenous injection of RNA NPs with HER2-specific aptamers resulted in strong binding to tumors but not to healthy tissues. XBP1 deletion by RNA NPs impaired angiogenesis and inhibited cell proliferation, significantly suppressed breast cancer growth, and promoted the sensitization of chemotherapy in an HER2+ breast cancer mouse model. Overall, these results reveal the function of XBP1 in HER2+ breast cancer development and chemoresistance and imply that targeting XBP1 by RNA NPs may offer an easy and promising strategy for a combination treatment of breast cancer in the future.

• Authors: Long Zhang, Chaofeng Mu, Tinghong Zhang, Yingying Wang, Yili Wang, Luhui Fan, Cong Liu, Hao Chen, Jianliang Shen, Kun Wei, Huaqiong Li
• Journal: ACS applied materials & interfaces (ACS Appl Mater Interfaces) Vol. 12 Issue 29 Pg. 32360-32371 (Jul 22 2020) ISSN: 1944-8252 [Electronic] United States
• PMID: 32613835 (Publication Type: Journal Article)

Chemical References

• Aptamers, Nucleotide
• RNA, Small Interfering
• X-Box Binding Protein 1
• XBP1 protein, human
• ERBB2 protein, human
• Receptor, ErbB-2

Topics

• Animals
• Aptamers, Nucleotide (administration & dosage, chemistry)
• Cell Proliferation
• Female
• Humans
• Injections, Intravenous
• Mammary Neoplasms, Experimental (metabolism, pathology)
• Mice
• Nanoparticles (administration & dosage, chemistry)
• Particle Size
• RNA, Small Interfering (administration & dosage, chemistry, metabolism)
• Receptor, ErbB-2 (metabolism)
• Surface Properties
• Triple Negative Breast Neoplasms (metabolism, pathology)
• X-Box Binding Protein 1 (chemistry, genetics, metabolism)